L-type Ca2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Ogura, Toshitsugu ^a   Shuba, Lesya M ^a   McDonald, Terence F ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Daidzein; Genistein; Orthovanadate; Protein tyrosine kinase; Tyrphostins

Indexed keywords

CALCIUM CHANNEL; DAIDZEIN; GENISTEIN; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN; CADMIUM; CALCIUM CHANNEL L TYPE; ENZYME INHIBITOR; ESTROGEN; ISOFLAVONE DERIVATIVE; PROTEIN TYROSINE KINASE; TYROSINE; TYRPHOSTIN A23; VANADIC ACID;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; DRUG EFFECT; GUINEA PIG; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CELL CULTURE; CELL MEMBRANE POTENTIAL; CHEMISTRY; CYTOLOGY; ELECTROPHYSIOLOGY; ENZYMOLOGY; HEART MUSCLE; METABOLISM; MUSCLE CELL; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CADMIUM; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; ESTROGENS, NON-STEROIDAL; GENISTEIN; GUINEA PIGS; ISOFLAVONES; MEMBRANE POTENTIALS; MUSCLE FIBERS; MYOCARDIUM; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TYROSINE; TYRPHOSTINS; VANADATES;

EID: 0033129520     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.5.h1724     Document Type: Article

References (34)

1. Agbotounou, W. K., A. Levitzki, A. Jacquemin-Sablon, and J. Pierre. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells. Mol. Pharmacol. 45: 922-931, 1994.
2. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukumi. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
3. Bilder, G. E., J. A. Krawiec, K. McVety, A. Gazit, C. Gilon, R. Lyall, A. Zilberstein, A. Levitzki, M. H. Perrone, and A. B. Schreiber. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am. J. Physiol. 260 (Cell Physiol. 29): C721-C730, 1991.
4. Bischof, G., B. Illek, W. W. Reenstra, and T. E. Machen. Role for tyrosine kinases in carbachol-regulated Ca entry into colonie epithelial cells. Am. J. Physiol. 268 (Cell Physiol. 37): C154-0161, 1995.
5. 3 cells. J. Biol. Chem. 271: 9441-9446, 1996.
6. Chiang, C.-E., S.-A. Chen, M.-S. Chang, C.-I. Lin, and H.-N. Luk. Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes. Biochem. Biophys. Res. Commun. 223: 598-603, 1996.
7. Gazit, A., P. Yaish, C. Gilon, and A. Levitzki. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32: 2344-2352, 1989.
8. Gordon, J. A. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201: 477-482, 1991.
9. Harvey, R. D., C. D. Clark, and J. R. Hume. Chloride current in mammalian cardiac myocytes. Novel mechanism for autonomic regulation of action potential duration and resting membrane potential. J. Gen. Physiol. 95: 1077-1102, 1990.
10. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265: 2896-2902, 1990.
11. Hollenberg, M. D. Tyrosine kinase-mediated signal transduction pathways and the actions of polypeptide growth factors and G-protein-coupled agonists in smooth muscle. Mol. Cell. Biochem. 149-150: 77-85, 1995.
12. Holmes, T. C., D. A. Fadool, and I. B. Levitan. Tyrosine phosphorylation of the Kv1.3 potassium channel. J. Neurosci. 16: 1581-1590, 1996.
13. 1 muscarinic acetylcholine receptor. Cell 75: 1145-1156, 1993.
14. Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
15. Illek, B., H. Fischer, G. F. Santos, J. H. Widdicombe, T. E. Machen, and W. W. Reenstra. cAMP-independent activation of CFTR C1 channels by the tyrosine kinase inhibitor genistein. Am. J. Physiol. 268 (Cell Physiol. 37): C886-C893, 1995.
16. Imoto, M., H. Kakeya, T. Sawa, C. Hayashi, M. Hamada, T. Takeuchi, and K. Umezawa. Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation, and characterization. J. Antibiot. (Tokyo) 46: 1342-1346, 1993.
17. 2+ current in neonatal and adult rat ventricular myocytes by the tyrosine kinase inhibitor, genistein. Eur. J. Pharmacol. 345: 309-314, 1998.
18. Kusaka, M., and N. Sperelakis. Inhibition of L-type calcium current by genistein, a tyrosine kinase inhibitor, in pregnant rat myometrial cells. Biochim. Biophys. Acta 1240: 196-200, 1995.
19. Liu, H., K. Li, and N. Sperelakis. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Can. J. Physiol. Pharmacol. 75: 1058-1062, 1997.
20. Liu, H., and N. Sperelakis. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein. Can. J. Physiol. Pharmacol. 75: 1063-1068, 1997.
21. McDonald, T. F., S. Pelzer, W. Trautwein, and D. J. Pelzer. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74: 365-507, 1994.
22. 2+ channel currents in NG108-15 cells. Pflügers Arch. 436: 127-132, 1998.
23. Ogura, T., L. M. Shuba, and T. F. McDonald. Action potentials, ionic currents and cell water in guinea pig ventricular preparations exposed to dimethyl sulfoxide. J. Pharmacol. Exp. Ther. 273: 1273-1286, 1995.
24. Shuba, L. M., T. Asai, S. Pelzer, and T. F. McDonald. Activation of cardiac chloride conductance by the tyrosine kinase inhibitor, genistein. Br. J. Pharmacol. 119: 335-345, 1996.
25. Shuba, L. M., and T. F. McDonald. Synergistic activation of guinea-pig cardiac cystic fibrosis transmembrane conductance regulator by the tyrosine kinase inhibitor genistein and cAMP. J. Physiol. (Lond.) 505: 23-40, 1997.
26. Strauss, O., S. Mergler, and M. Wiederholt. Regulation of L-type calcium channels by protein tyrosine kinase and protein kinase C in cultured rat and human retinal pigment epithelial cells. FASEB J. 11: 859-867, 1997.
27. Swarup, G., S. Cohen, and D. L. Garbers. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 107: 1104-1109, 1982.
28. Swarup, G., K. V. Speeg, Jr., S. Cohen, and D. L. Garbers. Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J. Biol. Chem. 257: 7298-7301, 1982.
29. 2+ current in feline atrial myocytes. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H204-H212, 1998.
30. Wang, Y. T., and M. W. Salter. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369: 233-235, 1994.
31. 2+-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 93: 1721-1725, 1996.
32. Wijetunge, S., C. Aalkjaer, M. Schachter, and A. D. Hughes. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623, 1992.
33. Wijetunge, S., J. S. Lymn, and A. D. Hughes. Effect of inhibition of tyrosine phosphatases on voltage-operated calcium channel currents in rabbit isolated ear artery cells. Br. J. Pharmacol. 124: 307-316, 1998.
34. Yokoshiki, H., K. Sumii, and N. Sperelakis. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein, and its inactive analog, daidzein. J. Mol. Cell. Cardiol. 28: 807-814, 1996.